Drug targeting to the colon with lectins and neoglycoconjugates.
about
Insight to drug delivery aspects for colorectal cancerCan nanomedicines kill cancer stem cells?Polymeric nanoparticles for targeted treatment in oncology: current insightsLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors.New paradigm for tumor theranostic methodology using bacteria-based microrobot.Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.A glycobiology review: carbohydrates, lectins and implications in cancer therapeuticsPharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategiesNovel drug delivery strategies for the treatment of inflammatory bowel disease.Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.Carbohydrate-based experimental therapeutics for cancer, HIV/AIDS and other diseasesTheranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives.Engineering galectin-glycan interactions for immunotherapy and immunomodulationInterest of glycolipids in drug delivery: from physicochemical properties to drug targeting.Multifunctional dendritic polymers in nanomedicine: opportunities and challenges.Strategies for non-invasive delivery of biologics.Binding sugars: from natural lectins to synthetic receptors and engineered neolectins.Orally active-targeted drug delivery systems for proteins and peptides.Marine lectins and their medicinal applications.The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.LHRH-conjugated micelles for targeted delivery of antiandrogen to treat advanced prostate cancer.Design of novel chemotherapeutic delivery systems for colon cancer therapy based on oral polymeric nanoparticles.Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.Plant protein-based hydrophobic fine and ultrafine carrier particles in drug delivery systems.Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors.Analysis of unconventional approaches for the rapid detection of surface lectin binding ligands on human cell lines.Direct targeting of cancer cells: a multiparameter approach.Multiparticulate system for colon targeted delivery of ondansetronHighly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers.Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and ApplicationsSynthetic lectin arrays for the detection and discrimination of cancer associated glycans and cell lines.New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging.Effect of chitosan coating on a bacteria-based alginate microrobot.ConBr, A Lectin Purified from the Seeds of Canavalia brasiliensis, Protects Against Ischemia in Organotypic Culture of Rat Hippocampus: Potential Implication of Voltage-Gated Calcium Channels.ConBr, a lectin from Canavalia brasiliensis seeds, modulates signaling pathways and increases BDNF expression probably via a glycosylated target.Development of bacteria-based microrobot using biocompatible poly(ethylene glycol).
P2860
Q26774682-1DCB0832-76B8-4C5C-89EA-323C42648AE1Q27022017-08D2CFD5-54C6-404C-9CB7-5AC3CB1534C3Q28087243-3F485801-BFEF-4691-A45D-119B7758FD58Q30366990-43DE4438-01CA-4EF1-9846-984382AD53BAQ30382105-3584BC19-51A3-4C04-8DA3-5C0418E166B0Q30558192-8E99A86C-8642-401D-B421-B451E8FE18C6Q33943901-72EE44F6-727C-4E97-A682-39FC71B6D420Q34524965-029D7ABF-4B18-492B-9D35-BC64FFCAD3B0Q35104714-F4C91E83-0B63-49EE-BED5-70C1CF66F080Q35837359-F00609CD-809B-4525-8899-2EC7004CDE57Q36143454-9B243D84-36E8-4A46-B805-83B9662E4442Q36316765-BDE14643-8CA1-4D27-B41D-ED76DD8B790DQ36452190-0D95A02E-92DF-44AB-B3DD-79DDAAFB4C75Q36515536-FF976B22-7EEC-4628-8FD6-F34E5D380B22Q36777292-677EAE59-929D-4998-8211-996BCF3FDCF0Q37107168-B66D28A2-E715-4D1E-AA51-1567CCD691FEQ37780546-22F59950-85A3-4214-98CC-4DB68B4AB38EQ37967150-D25DB906-A0F2-4BC7-8B29-210E7497F1FEQ38013190-28FBFB1D-8575-4162-A339-8780A1CCA6B2Q38077027-73CF64FF-E91F-4537-B000-84984127D2A1Q38223053-D956CAB1-9268-4356-8F09-235ECC4A3E31Q38385723-AE8661CE-537E-4471-B8B9-07D419420272Q38645695-B7A9999A-824B-44A6-BFEC-21430E54BFB7Q38862706-80A29D36-7A05-48E4-B456-FE43982C0C1AQ38999341-550797F4-04B3-43BE-A650-5C49A59B10D7Q39041183-C7BC0DB7-B3A4-4986-86B2-1E01F0464BC8Q39139112-D52787D4-7879-491F-AA31-6C7C8821FE51Q39257007-2F5FA416-0962-4178-94EC-9A6958A4C507Q39462712-4CE2D0B4-2BFC-4C95-A0E3-557D64D19A61Q40329338-DDBA83F7-97A3-4FA1-8FE2-AE98455EBA63Q40369498-A3486956-DDF5-44D3-BEC5-AC98D362475DQ40965744-D4A445F8-720E-49A7-AE53-D44E139F15D3Q41971231-2B2ABF92-4DA7-4517-A9E0-0F99CC386195Q42175440-CB7CD88C-EC53-484B-899B-6BBB17E49241Q42379560-F923E141-EB32-4FBA-87BD-A3B4C54824E9Q43298812-FB66E18F-B271-4AD1-B7C6-F795AEC78AC7Q46056444-D832C0A9-2278-40C7-8ACE-241ACEC3EE0FQ46477382-17DEC88C-7AFF-49AD-9FFF-ED38FFB115DDQ48483887-502ACECC-B742-455C-8981-52D85CAAEF02Q50023169-93987E3A-F0B5-4717-9F8A-EF02EF70544A
P2860
Drug targeting to the colon with lectins and neoglycoconjugates.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Drug targeting to the colon with lectins and neoglycoconjugates.
@ast
Drug targeting to the colon with lectins and neoglycoconjugates.
@en
type
label
Drug targeting to the colon with lectins and neoglycoconjugates.
@ast
Drug targeting to the colon with lectins and neoglycoconjugates.
@en
prefLabel
Drug targeting to the colon with lectins and neoglycoconjugates.
@ast
Drug targeting to the colon with lectins and neoglycoconjugates.
@en
P1476
Drug targeting to the colon with lectins and neoglycoconjugates.
@en
P304
P356
10.1016/J.ADDR.2003.10.017
P407
P50
P577
2004-03-01T00:00:00Z